Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > THTX Weekly Report Card

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on May 30, 2021 2:32pm

110 Views

Post# 33294285

RE:RE:RE:RE:THTX Weekly Report Card

I think Spceo is trying hard to re ignite the stock price but the sense of urgency to adress the capital markets failings by management has somewhat lessened after All directors were re elected.
Any one who has seen the movie Cruella which came out last week would know that the 6th stage of Grief is REVENGE ..... That word is not in Spceo s vocabulary !!!!!
I hope that a new Director is appointed as promised soon but Unfortunately the process has been slowed..... I hope the new appointee coincides with the resignation of a current director

<< Previous

Bullboard Posts

Next >>

New Found Gold begins surface trenching at Queensway